Physician profile
David W Lee
NPI 1740402874
$3,354.46
in general payments reported to CMS, 2019-2025
33 companies · $332 in 2025
The $332 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $815 · 2020: $363 · 2022: $816 · 2023: $674 · 2024: $355 · 2025: $332.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,311 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,310.70 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $632.19 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $244.58 | 2019-2025 | |
| Lilly USA, LLC | $233.65 | 2019-2024 | Mounjaro, Zepbound, Emgality |
| Amgen INC. | $211.58 | 2019-2025 | Repatha, Otezla, Repatha |
| Glaxosmithkline, LLC. | $200.86 | 2019-2025 | Trelegy Ellipta, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $185.28 | 2020-2023 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $172.16 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $147.23 | 2019-2025 | Breztri, Airsupra |
| Abbvie INC. | $146.37 | 2019-2023 | |
| Curonix LLC | $129.47 | 2022 | |
| Stimwave Technologies Incorporated | $116.99 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $108.97 | 2020-2023 | Trulance, Xifaxan |
| Currax Pharmaceuticals LLC | $97.19 | 2019-2023 | Nexletol, Contrave |
| Novartis Pharmaceuticals Corporation | $90.35 | 2022-2023 | |
| Janssen Pharmaceuticals, INC | $70.14 | 2019-2023 | Xarelto |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $57.71 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Exact Sciences Corporation | $55.80 | 2023 | Cologuard Collection Kit |
| Amarin Pharma, INC. | $46.36 | 2020-2022 | |
| Sanofi-Aventis U.S. LLC | $45.23 | 2019 | |
| Vivus LLC | $44.11 | 2019-2020 | |
| Insulet Corporation | $40.98 | 2019 | |
| Allergan, INC. | $38.05 | 2019-2020 | |
| Sanofi Pasteur INC. | $34.04 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $30.26 | 2019-2022 | |
| Ironwood Pharmaceuticals, INC | $26.94 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $26.34 | 2019-2020 | |
| Abbott Laboratories | $24.35 | 2022 | |
| Gilead Sciences, INC. | $20.36 | 2020 | |
| Astellas Pharma US INC | $18.69 | 2022 | |
| Amneal Pharmaceuticals LLC | $18.60 | 2023 | Unithroid |
| Mannkind Corporation | $14.84 | 2019 | |
| Arbor Pharmaceuticals, INC. | $13.06 | 2019 | |
| Nalpropion Pharmaceuticals LLC | $11.73 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.